On Judge Sweet’s DNA Ruling: Good for Patients, Bad for Biz?
31 03 2010Folks are positively buzzing, it seems, about this ruling made on Tuesday by Manhattan federal judge Robert Sweet, in which he struck down several patents on human genes.
An article in the WSJ on Wednesday says that, according to medical experts, the ruling could ultimately be a boon for genetic research and a benefit for public health. Click here for Tuesday’s WSJ story on the ruling; here for Judge Sweet’s opinion; here for the Nathan Koppel’s overview of the issues, pubbed last December in the WSJ.
According to the Journal, when companies hold exclusive licenses for human genes, the effects can restrict competition to develop gene-based applications, inflate prices and slow innovation, some geneticists say.
The content in this post was found at http://blogs.wsj.com/law/2010/03/31/on-judge-sweets-dna-ruling-good-for-patients-bad-for-biz/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+wsj%2Flaw%2Ffeed+%28WSJ.com%3A+Law+Blog%29 and was not authored by the moderators of freeforafee.com. Clicking the title link will take you to the source of the post.
